Old Port Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.75M | Buy |
114,101
+4,695
| +4% | +$123K | 0.54% | 52 |
|
|
2026
Q1 | $3.07M | Buy |
109,406
+7,983
| +8% | +$213K | 0.71% | 41 |
|
|
2025
Q4 | $2.53M | Sell |
101,423
-4,247
| -4% | -$107K | 0.62% | 48 |
|
|
2025
Q3 | $2.69M | Buy |
105,670
+5,089
| +5% | +$126K | 0.68% | 44 |
|
|
2025
Q2 | $2.44M | Buy |
100,581
+11,288
| +13% | +$263K | 0.67% | 46 |
|
|
2025
Q1 | $2.26M | Buy |
89,293
+7,218
| +9% | +$189K | 0.67% | 52 |
|
|
2024
Q4 | $2.18M | Sell |
82,075
-6,528
| -7% | -$177K | 0.63% | 55 |
|
|
2024
Q3 | $2.56M | Sell |
88,603
-3,545
| -4% | -$103K | 0.71% | 44 |
|
|
2024
Q2 | $2.58M | Buy |
92,148
+1,769
| +2% | +$48.7K | 0.77% | 41 |
|
|
2024
Q1 | $2.51M | Buy |
90,379
+8,603
| +11% | +$239K | 0.77% | 42 |
|
|
2023
Q4 | $2.35M | Sell |
81,776
-15,134
| -16% | -$457K | 0.78% | 43 |
|
|
2023
Q3 | $3.21M | Buy |
+96,910
| New | +$3.43M | 1.17% | 15 |
|
|
2023
Q1 | $4.04M | Sell |
96,566
-1,046
| -1% | -$45.2K | 1.45% | 6 |
|
|
2022
Q4 | $5M | Sell |
97,612
-961
| -1% | -$46.1K | 1.88% | 4 |
|
|
2022
Q3 | $4.35M | Buy |
98,573
+627
| +0.6% | +$30.5K | 1.73% | 6 |
|
|
2022
Q2 | $5.06M | Sell |
97,946
-458
| -0.5% | -$23.3K | 1.96% | 3 |
|
|
2022
Q1 | $5.08M | Sell |
98,404
-2,130
| -2% | -$111K | 1.73% | 5 |
|
|
2021
Q4 | $5.51M | Buy |
100,534
+2,151
| +2% | +$107K | 1.87% | 5 |
|
|
2021
Q3 | $4.13M | Buy |
98,383
+955
| +1% | +$42.3K | 1.5% | 9 |
|
|
2021
Q2 | $3.89M | Buy |
97,428
+106
| +0.1% | +$4.12K | 1.4% | 10 |
|
|
2021
Q1 | $3.53M | Buy |
97,322
+201
| +0.2% | +$7.14K | 1.38% | 15 |
|
|
2020
Q4 | $3.58M | Sell |
97,121
-4,256
| -4% | -$156K | 1.55% | 13 |
|
|
2020
Q3 | $3.53M | Buy |
101,377
+3,009
| +3% | +$105K | 1.74% | 11 |
|
|
2020
Q2 | $3.05M | Buy |
98,368
+3,823
| +4% | +$130K | 1.6% | 15 |
|
|
2020
Q1 | $2.93M | Buy |
94,545
+2,243
| +2% | +$76.4K | 1.79% | 10 |
|
|
2019
Q4 | $3.4M | Buy |
92,302
+866
| +0.9% | +$30.8K | 1.64% | 12 |
|
|
2019
Q3 | $3.12M | Sell |
91,436
-600
| -0.7% | -$21.8K | 1.63% | 10 |
|
|
2019
Q2 | $3.88M | Buy |
92,036
+305
| +0.3% | +$12.1K | 1.99% | 6 |
|
|
2019
Q1 | $3.7M | Sell |
91,731
-3,040
| -3% | -$122K | 1.94% | 5 |
|
|
2018
Q4 | $3.8M | Buy |
+94,771
| New | +$3.93M | 2.13% | 3 |
|
|
2018
Q2 | $3.16M | Buy |
+91,831
| New | +$3.14M | 1.7% | 9 |
|
Other funds holding PFE
Old Port Advisors's PFE Position: Q2 2026 in Review
Old Port Advisors increased its Pfizer (PFE) stake by 4.3% in Q2 2026, buying an estimated $123K and bringing the position to 114,101 shares worth $2.75M. The position accounts for 0.54% of the portfolio, ranked #52.
Old Port Advisors first reported a position in PFE in Q2 2018 and has held it in 31 quarters since. The position peaked at $5.51M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Old Port Advisors held 114,101 shares of Pfizer worth $2.75M as of Q2 2026.
- Old Port Advisors bought 4,695 Pfizer shares in Q2 2026, an estimated $123K.
- Pfizer made up 0.54% of Old Port Advisors's portfolio in Q2 2026, its #52 holding.
- Old Port Advisors first reported a position in Pfizer in Q2 2018 and has held it in 31 quarters since.
- Old Port Advisors's Pfizer position peaked at $5.51M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.